IN2014MN01513A - - Google Patents

Download PDF

Info

Publication number
IN2014MN01513A
IN2014MN01513A IN1513MUN2014A IN2014MN01513A IN 2014MN01513 A IN2014MN01513 A IN 2014MN01513A IN 1513MUN2014 A IN1513MUN2014 A IN 1513MUN2014A IN 2014MN01513 A IN2014MN01513 A IN 2014MN01513A
Authority
IN
India
Prior art keywords
subject
allergic
peptides
timothy grass
methods
Prior art date
Application number
Other languages
English (en)
Inventor
Alessandro Sette
Veronique Schulten
Howard Grey
Bjoern Peters
Jason Greenbaum
Original Assignee
Jolla Inst Allergy Immunolog
Alessandro Sette
Veronique Schulten
Howard Grey
Bjoern Peters
Jason Greenbaum
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jolla Inst Allergy Immunolog, Alessandro Sette, Veronique Schulten, Howard Grey, Bjoern Peters, Jason Greenbaum filed Critical Jolla Inst Allergy Immunolog
Publication of IN2014MN01513A publication Critical patent/IN2014MN01513A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
IN1513MUN2014 2012-02-07 2013-02-07 IN2014MN01513A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261596156P 2012-02-07 2012-02-07
US201261734886P 2012-12-07 2012-12-07
PCT/US2013/025213 WO2013119863A1 (en) 2012-02-07 2013-02-07 Timothy grass allergens and methods and uses for immune response modulation

Publications (1)

Publication Number Publication Date
IN2014MN01513A true IN2014MN01513A (ru) 2015-09-11

Family

ID=48948025

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1513MUN2014 IN2014MN01513A (ru) 2012-02-07 2013-02-07

Country Status (13)

Country Link
US (1) US10428124B2 (ru)
EP (1) EP2812026A4 (ru)
JP (1) JP2015513527A (ru)
KR (1) KR20140129124A (ru)
CN (1) CN104203277A (ru)
AU (1) AU2013216993C1 (ru)
BR (1) BR112014019504A2 (ru)
CA (1) CA2864084A1 (ru)
EA (1) EA201491481A1 (ru)
HK (1) HK1204929A1 (ru)
IN (1) IN2014MN01513A (ru)
MX (1) MX2014009285A (ru)
WO (1) WO2013119863A1 (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015054217A2 (en) 2013-10-07 2015-04-16 La Jolla Institute For Allergy And Immunology Methods and uses for reducing an allergic response in a subject
WO2015054231A1 (en) 2013-10-07 2015-04-16 La Jolla Institute For Allergy And Immunology Methods and uses for identifying responders to allergy therapy
AU2014352986A1 (en) 2013-11-20 2016-06-16 Alk-Abello A/S Pan pollen immunogens and methods and uses thereof for immune response modulation
WO2015077442A2 (en) 2013-11-20 2015-05-28 La Jolla Institute For Allergy And Immunology Grass pollen immunogens and methods and uses for immune response modulation
US10059751B2 (en) 2013-12-23 2018-08-28 Alk-Abelló A/S Peptide combinations and uses thereof in treating dust mite allergy
WO2015131053A1 (en) 2014-02-28 2015-09-03 Alk-Abelló A/S Polypeptides derived from phl p and methods and uses thereof for immune response modulation
EP3925968A3 (en) * 2014-10-07 2022-03-02 Cytlimic Inc. Hsp70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell
WO2016143816A1 (ja) 2015-03-09 2016-09-15 日本電気株式会社 Ｇｐｃ３由来のペプチド、これを用いた癌の治療又は予防のための医薬組成物、免疫誘導剤、及び抗原提示細胞の製造方法
US10842848B2 (en) 2015-04-07 2020-11-24 Cytlimic Inc. Method for treating cancer by adminstering poly I:C and LAG-3-IgG fusion protein
US11291718B2 (en) 2016-10-11 2022-04-05 Cytlimic Inc. Method for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein
WO2018199341A1 (ja) * 2017-04-28 2018-11-01 学校法人藤田学園 アレルギーの抗原およびそのエピトープ

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214786B2 (en) * 2000-12-14 2007-05-08 Kovalic David K Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
AUPR775401A0 (en) * 2001-09-18 2001-10-11 Monash University Novel Epitopes and Uses Thereof
BR0312068A (pt) 2002-06-25 2005-03-29 Merck Patent Ges Mit Beschaenk Sequência de dna e preparação de alérgeno de pólen de gramìneas phl p 4 por métodos recombinantes
RU2323942C2 (ru) 2002-08-19 2008-05-10 Мерк Патент Гмбх ВАРИАНТЫ ОСНОВНОГО АЛЛЕРГЕНА Phl p 1 ИЗ ТИМОФЕЕВКИ ЛУГОВОЙ
MXPA05005528A (es) * 2002-11-26 2006-04-05 Alk Abello As Producto farmaceutico de alergeno.
EP2489726A3 (en) * 2005-01-12 2012-11-28 Monsanto Technology LLC Genes and uses for plant improvement
US20090070897A1 (en) * 2006-01-12 2009-03-12 Goldman Barry S Genes and uses for plant improvement
DK2244734T3 (en) 2008-02-01 2016-08-15 Murdoch Childrens Res Inst PROCEDURE FOR INDUCTION OF TOLERANCE ABOUT AN ALLERGY
EP2388268A1 (en) * 2010-05-18 2011-11-23 Stallergenes S.A. Recombinant Der p 2 expressed in Pichia pastoris as a "natural-like" allergen for immunotherapy and diagnostic purposes
CN103547287A (zh) 2010-10-15 2014-01-29 爱尔开-阿贝优公司 用衍生自变应原来源材料的无关抗原抑制超敏性免疫应答
EP2627354B1 (en) 2010-10-15 2015-07-15 ALK-Abelló A/S Suppression of a type 1 hypersensitivity immune response with an unrelated antigen
US9700071B2 (en) * 2012-03-26 2017-07-11 Axcella Health Inc. Nutritive fragments, proteins and methods
DK2838556T3 (en) 2012-04-16 2017-04-10 Alk-Abelló As Plant profile polypeptides for use in non-specific allergy immunotherapy

Also Published As

Publication number Publication date
BR112014019504A2 (pt) 2017-06-27
CN104203277A (zh) 2014-12-10
WO2013119863A1 (en) 2013-08-15
HK1204929A1 (en) 2015-12-11
US10428124B2 (en) 2019-10-01
EA201491481A1 (ru) 2014-11-28
AU2013216993C1 (en) 2017-01-19
CA2864084A1 (en) 2013-08-15
KR20140129124A (ko) 2014-11-06
AU2013216993A1 (en) 2014-08-21
US20150023992A1 (en) 2015-01-22
MX2014009285A (es) 2015-02-04
EP2812026A1 (en) 2014-12-17
EP2812026A4 (en) 2016-04-27
AU2013216993B2 (en) 2016-09-15
JP2015513527A (ja) 2015-05-14

Similar Documents

Publication Publication Date Title
IN2014MN01513A (ru)
CA2863861A1 (en) Epitopes from allergen proteins and methods and uses for immune response modulation
MX2019011952A (es) Proteina anti-garp y sus usos.
HK1216487A1 (zh) 具有穩定的乳液體系的基於氨基酸和蛋白水解物的配方食品
MX2021006017A (es) Polipeptidos de folistatina y sus usos.
EA201590451A1 (ru) Способ лечения меланомы с применением вируса простого герпеса и ингибитора иммунной контрольной точки
SG194755A1 (en) Pre-fusion rsv f antigens
WO2013106834A3 (en) Immunogenic wt-1 peptides and methods of use thereof
BR112013020500A8 (pt) anticorpo isolado, recombinante ou purificado
BR112015013127A2 (pt) imunoterapia com agentes de ligação
BR112014033116A2 (pt) anticorpos para tau
MX348071B (es) Variantes de fc.
WO2011113019A3 (en) Ctla4 proteins and their uses
BR112016011025A2 (pt) polipeptídeos anticorpo e seus usos
TR201905619T4 (tr) Alerji aşısı olarak peptit taşıyıcı füzyon proteinleri.
IN2014CN04498A (ru)
WO2014204816A3 (en) Method for assessing protein identity and stability
WO2014144721A3 (en) Treating th2-mediated diseases by inhibition of bromodomain-comprising proteins brd7 and brd9
BR112013018742A2 (pt) cya-transportador de polipeptídeo(s) e use para induzir tanto as terapias e resposta imunitária profilática
EP3087185A4 (en) Antibodies comprising c-terminal light chain polypeptide extensions and conjugates and methods of use thereof
WO2016131000A3 (en) Tolerance therapeutic for treating polypeptide induced allergy
BR112014011481A2 (pt) hidrolisado de colágeno e seu uso
PH12015501870B1 (en) Nutritional compositions containing a peptide component with adiponectin stimulating properties and uses thereof
BR112014028130A2 (pt) Sal de cloridrato de um peptídeo, composição farmacêutica, uso de um sal de cloridrato, uso de uma composição farmacêutica, e, método para evitar ou tratar alergia a gatos
WO2011123858A3 (en) Ccn3 peptides and analogs thereof for therapeutic use